ANDREW WARNER: Open Payments
NPI 1346505864 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$893 in 13 payments from 9 companies in 2025. Trend: 2023 $224 · 2024 $226 · 2025 $893
Food & beverage: $893
| Company | Payments | Amount |
|---|---|---|
| AOP Health US, LLC | 1 | $443 |
| BridgeBio Pharma, Inc. | 2 | $172 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $90 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $47 |
| Kestra Medical Technology Services, Inc. | 1 | $46 |
| ABIOMED | 1 | $42 |
| Amgen Inc. | 1 | $22 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $16 |
| E.R. Squibb & Sons, L.L.C. | 1 | $14 |
Products named: Rapiblyk, Attruby, LifeVest, JARDIANCE, Assure WCD, Repatha, Kerendia, ELIQUIS.
Industry payments across NY — which companies pay providers there.
